Clinical Trial Update: Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety, tolerability and pharmacokinetics of AZD5055 after single and multiple ascending doses in healthy participants, with Idiop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• AZD5055

Snippet

Sponsor: AstraZeneca | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED